Immunology

  • A drug that binds to allergy-causing antibodies can protect children from dangerous reactions to accidentally eating allergy-triggering foods, a Stanford Medicine-led study found.

  • Why young kids don’t get severe COVID

    Children’s noses pack a punch that could help explain COVID-19’s typically mild course in young kids. Researchers hope to parlay that ‘nasal magic’ into increased protections for adults.

  • Drug boosts nerve growth, muscle strength

    A drug that boosts strength in injured or aging mice restores connections between nerves and muscle and suggests ways to combat weakness in humans due to aging, injury or disease.

  • New COVID-19 vaccine

    In a study led by Stanford Medicine researchers, a low-cost COVID-19 vaccine that does not require refrigeration provided immunity in rhesus monkeys for one year.

  • mRNA vaccine beats infection

    Stanford Medicine researchers have shown that prior SARS-CoV-2 infection reduces killer T cells’ response to vaccination. These cells are crucial for eliminating the virus from the body.

  • Osteoarthritis linked to allergic inflammation

    A connection found between asthma, eczema and osteoarthritis indicates that drugs to treat allergic conditions could be used in future studies aimed at slowing the progression of osteoarthritis.

  • Myc-caused sugar changes protect cancers

    A novel Stanford School of Medicine partnership uncovers a direct link between a cancer-associated gene, Myc, and sugar patterns on cancer cell surfaces that tell immune cells to stand down.

  • Long-COVID clinical trials underway

    Developing the right treatment for long COVID depends on figuring out what’s causing it. Stanford Medicine researchers are bent on learning more about the people who have it to find out.

  • Cancer cells become cancer cure

    Researchers found that when they turned cancer cells into immune cells, they were able to teach other immune cells how to attack cancer.

  • One-and-done COVID-19 drug successful

    A single dose of lambda-interferon reduced hospitalization among COVID-19 outpatients in a late-stage study spearheaded by a Stanford Medicine virologist.

  • How COVID-19 virus infects nasal cells

    A discovery by Stanford Medicine researchers and colleagues may pave the way for a “morning after” or prophylactic nasal spray to prevent infection.

  • Blood test identifies infections

    A diagnostic test developed by Stanford Medicine scientists can separate bacterial and viral infections with 90% accuracy, the first to meet standards set by the World Health Organization.


Related Websites